Vaccinex Net Receivables vs Common Stock Analysis

VCNX Stock

USD 3.62 0.02 0.56%

Vaccinex financial indicator trend analysis is much more than just breaking down Vaccinex prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaccinex is a good investment. Please check the relationship between Vaccinex Net Receivables and its Common Stock accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaccinex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.

Net Receivables vs Common Stock

Net Receivables vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vaccinex Net Receivables account and Common Stock. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Vaccinex's Net Receivables and Common Stock is 0.53. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Common Stock in the same time period over historical financial statements of Vaccinex, assuming nothing else is changed. The correlation between historical values of Vaccinex's Net Receivables and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Vaccinex are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Net Receivables i.e., Vaccinex's Net Receivables and Common Stock go up and down completely randomly.

Correlation Coefficient

0.53

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Net Receivables

Common Stock

Most indicators from Vaccinex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaccinex current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaccinex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.Issuance Of Capital Stock is likely to rise to about 18.7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 6.5 M in 2024.

	2023	2024 (projected)
Depreciation And Amortization	119K	181K
Interest Income	20.7K	19.7K

Depreciation And Amortization Interest Income

Vaccinex fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Short Long Term Debt
Total Assets		0.63	0.35	0.35	-0.17	-0.6	0.57	-0.36	-0.65	-0.32	-0.13	0.66	-0.36	-0.29	-0.04	0.98	0.22	0.02	0.58	-0.48	0.58	0.68	0.49	0.17	0.1	0.6
Short Long Term Debt Total	0.63		0.61	0.76	-0.84	-0.44	0.26	-0.12	-0.18	-0.03	0.6	0.48	-0.12	-0.32	0.33	0.65	0.29	-0.28	0.45	0.23	0.44	0.14	0.21	0.64	-0.43	1.0
Other Current Liab	0.35	0.61		0.41	-0.49	-0.23	0.16	-0.06	0.09	0.04	0.48	-0.21	-0.06	0.09	0.16	0.33	0.65	0.02	0.26	0.1	0.27	-0.13	0.08	0.28	-0.31	0.62
Total Current Liabilities	0.35	0.76	0.41		-0.81	-0.28	0.19	-0.28	0.22	-0.13	0.7	0.43	-0.28	-0.26	0.17	0.36	0.22	-0.02	0.29	0.06	0.35	0.1	0.18	0.93	-0.35	0.76
Total Stockholder Equity	-0.17	-0.84	-0.49	-0.81		0.28	0.02	0.06	-0.27	-0.07	-0.78	-0.23	0.06	0.23	-0.51	-0.19	-0.26	0.23	-0.28	-0.56	-0.18	0.16	0.03	-0.82	0.54	-0.85
Other Liab	-0.6	-0.44	-0.23	-0.28	0.28		-0.81	0.85	0.61	0.79	0.29	-0.62	0.85	0.78	0.15	-0.54	-0.54	-0.51	-0.99	0.3	-0.87	-0.75	-0.85	-0.06	-0.53	-0.41
Net Tangible Assets	0.57	0.26	0.16	0.19	0.02	-0.81		-0.86	-0.68	-0.92	-0.35	0.51	-0.86	-0.82	-0.67	0.48	0.62	0.69	0.79	-0.65	0.94	0.77	0.97	-0.14	0.75	0.21
Property Plant And Equipment Net	-0.36	-0.12	-0.06	-0.28	0.06	0.85	-0.86		0.42	0.94	0.37	-0.49	1.0	0.76	0.49	-0.27	-0.56	-0.8	-0.84	0.56	-0.85	-0.77	-0.91	-0.06	-0.75	-0.08
Net Debt	-0.65	-0.18	0.09	0.22	-0.27	0.61	-0.68	0.42		0.49	0.59	-0.66	0.42	0.58	0.35	-0.66	-0.04	-0.1	-0.61	0.46	-0.66	-0.78	-0.67	0.45	-0.52	-0.14
Retained Earnings	-0.32	-0.03	0.04	-0.13	-0.07	0.79	-0.92	0.94	0.49		0.44	-0.4	0.94	0.82	0.66	-0.2	-0.61	-0.86	-0.76	0.61	-0.84	-0.72	-0.94	0.14	-0.86	0.02
Accounts Payable	-0.13	0.6	0.48	0.7	-0.78	0.29	-0.35	0.37	0.59	0.44		-0.16	0.37	0.16	0.38	-0.08	0.07	-0.42	-0.27	0.56	-0.17	-0.6	-0.38	0.74	-0.77	0.63
Cash	0.66	0.48	-0.21	0.43	-0.23	-0.62	0.51	-0.49	-0.66	-0.4	-0.16		-0.49	-0.62	-0.03	0.72	-0.2	-0.05	0.62	-0.29	0.6	0.77	0.56	0.3	0.19	0.45
Non Current Assets Total	-0.36	-0.12	-0.06	-0.28	0.06	0.85	-0.86	1.0	0.42	0.94	0.37	-0.49		0.76	0.49	-0.27	-0.56	-0.8	-0.84	0.56	-0.85	-0.77	-0.91	-0.06	-0.75	-0.08
Non Currrent Assets Other	-0.29	-0.32	0.09	-0.26	0.23	0.78	-0.82	0.76	0.58	0.82	0.16	-0.62	0.76		0.45	-0.25	-0.38	-0.47	-0.76	0.22	-0.86	-0.62	-0.87	-0.01	-0.59	-0.28
Long Term Debt	-0.04	0.33	0.16	0.17	-0.51	0.15	-0.67	0.49	0.35	0.66	0.38	-0.03	0.49	0.45		0.04	-0.35	-0.67	-0.14	0.75	-0.51	-0.38	-0.64	0.43	-0.76	0.38
Cash And Short Term Investments	0.98	0.65	0.33	0.36	-0.19	-0.54	0.48	-0.27	-0.66	-0.2	-0.08	0.72	-0.27	-0.25	0.04		0.06	-0.14	0.54	-0.41	0.53	0.64	0.42	0.2	-0.01	0.63
Net Receivables	0.22	0.29	0.65	0.22	-0.26	-0.54	0.62	-0.56	-0.04	-0.61	0.07	-0.2	-0.56	-0.38	-0.35	0.06		0.7	0.51	-0.21	0.56	0.16	0.54	0.0	0.38	0.27
Common Stock Shares Outstanding	0.02	-0.28	0.02	-0.02	0.23	-0.51	0.69	-0.8	-0.1	-0.86	-0.42	-0.05	-0.8	-0.47	-0.67	-0.14	0.7		0.47	-0.6	0.53	0.43	0.68	-0.21	0.84	-0.31
Long Term Debt Total	0.58	0.45	0.26	0.29	-0.28	-0.99	0.79	-0.84	-0.61	-0.76	-0.27	0.62	-0.84	-0.76	-0.14	0.54	0.51	0.47		-0.28	0.88	0.73	0.84	0.07	0.5	0.41
Non Current Liabilities Total	-0.48	0.23	0.1	0.06	-0.56	0.3	-0.65	0.56	0.46	0.61	0.56	-0.29	0.56	0.22	0.75	-0.41	-0.21	-0.6	-0.28		-0.48	-0.67	-0.61	0.27	-0.69	0.27
Capital Surpluse	0.58	0.44	0.27	0.35	-0.18	-0.87	0.94	-0.85	-0.66	-0.84	-0.17	0.6	-0.85	-0.86	-0.51	0.53	0.56	0.53	0.88	-0.48		0.72	0.96	0.02	0.58	0.39
Other Current Assets	0.68	0.14	-0.13	0.1	0.16	-0.75	0.77	-0.77	-0.78	-0.72	-0.6	0.77	-0.77	-0.62	-0.38	0.64	0.16	0.43	0.73	-0.67	0.72		0.78	-0.1	0.65	0.1
Other Stockholder Equity	0.49	0.21	0.08	0.18	0.03	-0.85	0.97	-0.91	-0.67	-0.94	-0.38	0.56	-0.91	-0.87	-0.64	0.42	0.54	0.68	0.84	-0.61	0.96	0.78		-0.13	0.77	0.15
Total Liab	0.17	0.64	0.28	0.93	-0.82	-0.06	-0.14	-0.06	0.45	0.14	0.74	0.3	-0.06	-0.01	0.43	0.2	0.0	-0.21	0.07	0.27	0.02	-0.1	-0.13		-0.55	0.66
Property Plant And Equipment Gross	0.1	-0.43	-0.31	-0.35	0.54	-0.53	0.75	-0.75	-0.52	-0.86	-0.77	0.19	-0.75	-0.59	-0.76	-0.01	0.38	0.84	0.5	-0.69	0.58	0.65	0.77	-0.55		-0.48
Short Long Term Debt	0.6	1.0	0.62	0.76	-0.85	-0.41	0.21	-0.08	-0.14	0.02	0.63	0.45	-0.08	-0.28	0.38	0.63	0.27	-0.31	0.41	0.27	0.39	0.1	0.15	0.66	-0.48

Click cells to compare fundamentals

Vaccinex Account Relationship Matchups

Vaccinex fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	4.6M	11.7M	9.8M	8.0M	3.6M	6.8M
Other Current Liab	3.7M	1.9M	980K	617K	3.4M	1.9M
Total Current Liabilities	6.9M	13.2M	2.3M	2.5M	5.9M	4.6M
Total Stockholder Equity	(26.2M)	(26.6M)	7.4M	5.2M	(2.3M)	(2.4M)
Net Tangible Assets	(8.6M)	(26.2M)	(26.6M)	7.4M	8.5M	8.9M
Property Plant And Equipment Net	594K	416K	438K	499K	282K	416.4K
Net Debt	(2.8M)	(1.4M)	(8.2M)	(5.9M)	(1.3M)	(1.4M)
Retained Earnings	(248.6M)	(277.5M)	(299.9M)	(319.7M)	(339.9M)	(356.9M)
Accounts Payable	3.2M	3.2M	1.1M	1.5M	2.0M	1.8M
Cash	2.8M	10.6M	8.6M	6.4M	1.5M	1.5M
Non Current Assets Total	594K	416K	438K	499K	282K	416.4K
Non Currrent Assets Other	(594K)	(416K)	(438K)	(499K)	(1.0)	(1.05)
Cash And Short Term Investments	2.8M	10.6M	8.6M	6.4M	1.5M	1.5M
Net Receivables	898K	157K	0.0	175K	961K	1.0M
Common Stock Shares Outstanding	61.3K	89.5K	137.4K	202.1K	463.7K	486.8K
Liabilities And Stockholders Equity	4.6M	11.7M	9.8M	8.0M	3.6M	6.8M
Non Current Liabilities Total	3.7M	1.1M	175K	247K	26K	24.7K
Other Current Assets	336K	1.1M	1.6M	912K	853K	946.6K
Other Stockholder Equity	222.4M	250.9M	307.3M	324.9M	337.6M	244.4M
Total Liab	6.9M	14.3M	2.4M	2.8M	5.9M	5.3M
Property Plant And Equipment Gross	594K	416K	7.5M	7.8M	7.4M	7.7M
Total Current Assets	4.0M	11.3M	9.4M	7.5M	3.3M	6.4M
Property Plant Equipment	604K	594K	416K	438K	394.2K	451.1K
Net Invested Capital	(26.2M)	(17.4M)	7.7M	5.4M	(2.2M)	(2.3M)
Net Working Capital	(2.9M)	(1.9M)	7.1M	4.9M	(2.6M)	(2.4M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Vaccinex Stock Analysis

When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vaccinex Net Receivables vs Common Stock Analysis

Net Receivables vs Common Stock

Net Receivables vs Common Stock Correlation Analysis

Correlation Coefficient

Net Receivables

Common Stock

Vaccinex fundamental ratios Correlations

Vaccinex Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Vaccinex fundamental ratios Accounts

Also Currently Popular

Additional Tools for Vaccinex Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.98	Total Assets
Other Stockholder Equity	+ 0.97	Net Tangible Assets
Other Stockholder Equity	+ 0.96	Capital Surpluse
Capital Surpluse	+ 0.94	Net Tangible Assets

Long Term Debt Total	- 0.99	Other Liab
Other Stockholder Equity	- 0.94	Retained Earnings
Retained Earnings	- 0.92	Net Tangible Assets
Other Stockholder Equity	- 0.91	Non Current Assets Total
Other Stockholder Equity	- 0.91	Property Plant And Equipment Net
Other Stockholder Equity	- 0.87	Non Currrent Assets Other